tiprankstipranks
Trending News
More News >
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL
US Market

Autolus Therapeutics (AUTL) Stock Forecast & Price Target

Compare
668 Followers
See the Price Targets and Ratings of:

AUTL Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Autolus
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AUTL Stock 12 Month Forecast

Average Price Target

$8.00
▲(241.88%Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Autolus Therapeutics in the last 3 months. The average price target is $8.00 with a high forecast of $10.00 and a low forecast of $6.00. The average price target represents a 241.88% change from the last price of $2.34.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","11":"$11","2.75":"$2.75","5.5":"$5.5","8.25":"$8.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.75,5.5,8.25,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.35,2.0153846153846153,2.680769230769231,3.3461538461538467,4.011538461538462,4.676923076923078,5.342307692307693,6.007692307692308,6.673076923076923,7.338461538461539,8.003846153846155,8.66923076923077,9.334615384615386,{"y":10,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.35,1.8615384615384616,2.3730769230769235,2.884615384615385,3.3961538461538465,3.907692307692308,4.41923076923077,4.930769230769231,5.442307692307693,5.953846153846154,6.465384615384616,6.976923076923077,7.488461538461539,{"y":8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.35,1.7076923076923078,2.0653846153846156,2.4230769230769234,2.7807692307692307,3.138461538461539,3.496153846153846,3.853846153846154,4.211538461538462,4.569230769230769,4.926923076923077,5.284615384615385,5.642307692307693,{"y":6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.23,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.68,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.19,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.51,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.93,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.6,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.5,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.26,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.35,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.73,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.41,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.35,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$10.00Average Price Target$8.00Lowest Price Target$6.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on AUTL
TipRanks AITipRanks
Not Ranked
TipRanks
$2.5
Hold
6.84%
Upside
Reiterated
06/07/25
The overall score is primarily influenced by financial performance challenges, particularly profitability and cash flow issues. Strong technical momentum and positive earnings call insights slightly offset these concerns, but valuation remains a risk with negative earnings.
Truist Financial Analyst forecast on AUTL
Asthika GoonewardeneTruist Financial
Truist Financial
Buy
Reiterated
05/09/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vericel (NASDAQ: VCEL), Autolus Therapeutics (NASDAQ: AUTL) and Pacira Pharmaceuticals (NASDAQ: PCRX)
William Blair Analyst forecast on AUTL
Matt PhippsWilliam Blair
William Blair
Buy
Reiterated
05/08/25
Strong Market Entry and Strategic Expansion Drive Buy Rating for Autolus
Needham Analyst forecast on AUTL
Gil BlumNeedham
Needham
$10
Buy
327.35%
Upside
Reiterated
05/08/25
Autolus Therapeutics: Strong Q1 Performance and Strategic Expansion Justify Buy Rating
Wells Fargo Analyst forecast on AUTL
Yanan ZhuWells Fargo
Wells Fargo
$8$6
Buy
156.41%
Upside
Reiterated
03/20/25
Wells Fargo Keeps Their Buy Rating on Autolus Therapeutics (AUTL)
Mizuho Securities Analyst forecast on AUTL
Salim SyedMizuho Securities
Mizuho Securities
Buy
Reiterated
03/20/25
Positive Outlook and Buy Rating for Autolus Therapeutics Driven by Strategic Developments and Promising Prospects
Goldman Sachs Analyst forecast on AUTL
Rajan SharmaGoldman Sachs
Goldman Sachs
$7.6
Buy
224.79%
Upside
Upgraded
11/18/24
Autolus Therapeutics: FDA Approval of Aucatzyl De-Risks Platform, Significant Upside Anticipated
Redburn Atlantic Analyst forecast on AUTL
Simon Baker CFARedburn Atlantic
Redburn Atlantic
$13
Buy
455.56%
Upside
Upgraded
11/15/24
Autolus Therapeutics upgraded to Buy from Neutral at Redburn AtlanticAutolus Therapeutics upgraded to Buy from Neutral at Redburn Atlantic
Jefferies Analyst forecast on AUTL
Kelly ShiJefferies
Jefferies
$13
Buy
455.56%
Upside
Reiterated
11/12/24
Jefferies Reaffirms Their Buy Rating on Autolus Therapeutics (AUTL)
Deutsche Bank  Analyst forecast on AUTL
James ShinDeutsche Bank
Deutsche Bank
$10
Buy
327.35%
Upside
Reiterated
08/09/24
Buy Rating Affirmed for Autolus Therapeutics Amid Strong Commercial Prospects and Solid Financials
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on AUTL
TipRanks AITipRanks
Not Ranked
TipRanks
$2.5
Hold
6.84%
Upside
Reiterated
06/07/25
The overall score is primarily influenced by financial performance challenges, particularly profitability and cash flow issues. Strong technical momentum and positive earnings call insights slightly offset these concerns, but valuation remains a risk with negative earnings.
Truist Financial Analyst forecast on AUTL
Asthika GoonewardeneTruist Financial
Truist Financial
Buy
Reiterated
05/09/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vericel (NASDAQ: VCEL), Autolus Therapeutics (NASDAQ: AUTL) and Pacira Pharmaceuticals (NASDAQ: PCRX)
William Blair Analyst forecast on AUTL
Matt PhippsWilliam Blair
William Blair
Buy
Reiterated
05/08/25
Strong Market Entry and Strategic Expansion Drive Buy Rating for Autolus
Needham Analyst forecast on AUTL
Gil BlumNeedham
Needham
$10
Buy
327.35%
Upside
Reiterated
05/08/25
Autolus Therapeutics: Strong Q1 Performance and Strategic Expansion Justify Buy Rating
Wells Fargo Analyst forecast on AUTL
Yanan ZhuWells Fargo
Wells Fargo
$8$6
Buy
156.41%
Upside
Reiterated
03/20/25
Wells Fargo Keeps Their Buy Rating on Autolus Therapeutics (AUTL)
Mizuho Securities Analyst forecast on AUTL
Salim SyedMizuho Securities
Mizuho Securities
Buy
Reiterated
03/20/25
Positive Outlook and Buy Rating for Autolus Therapeutics Driven by Strategic Developments and Promising Prospects
Goldman Sachs Analyst forecast on AUTL
Rajan SharmaGoldman Sachs
Goldman Sachs
$7.6
Buy
224.79%
Upside
Upgraded
11/18/24
Autolus Therapeutics: FDA Approval of Aucatzyl De-Risks Platform, Significant Upside Anticipated
Redburn Atlantic Analyst forecast on AUTL
Simon Baker CFARedburn Atlantic
Redburn Atlantic
$13
Buy
455.56%
Upside
Upgraded
11/15/24
Autolus Therapeutics upgraded to Buy from Neutral at Redburn AtlanticAutolus Therapeutics upgraded to Buy from Neutral at Redburn Atlantic
Jefferies Analyst forecast on AUTL
Kelly ShiJefferies
Jefferies
$13
Buy
455.56%
Upside
Reiterated
11/12/24
Jefferies Reaffirms Their Buy Rating on Autolus Therapeutics (AUTL)
Deutsche Bank  Analyst forecast on AUTL
James ShinDeutsche Bank
Deutsche Bank
$10
Buy
327.35%
Upside
Reiterated
08/09/24
Buy Rating Affirmed for Autolus Therapeutics Amid Strong Commercial Prospects and Solid Financials
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Autolus Therapeutics

1 Month
xxx
Success Rate
11/26 ratings generated profit
42%
Average Return
+1.66%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 42.31% of your transactions generating a profit, with an average return of +1.66% per trade.
3 Months
xxx
Success Rate
13/28 ratings generated profit
46%
Average Return
+4.81%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.43% of your transactions generating a profit, with an average return of +4.81% per trade.
1 Year
Asthika GoonewardeneTruist Financial
Success Rate
8/18 ratings generated profit
44%
Average Return
+7.51%
reiterated a buy rating last month
Copying Asthika Goonewardene's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +7.51% per trade.
2 Years
xxx
Success Rate
12/28 ratings generated profit
43%
Average Return
-2.72%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of -2.72% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AUTL Analyst Recommendation Trends

Rating
Dec 24
Jan 25
Mar 25
Apr 25
May 25
Strong Buy
7
9
6
7
6
Buy
4
4
4
6
7
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
13
10
13
13
In the current month, AUTL has received 13 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AUTL average Analyst price target in the past 3 months is 8.00.
Each month's total comprises the sum of three months' worth of ratings.

AUTL Financial Forecast

AUTL Earnings Forecast

Next quarter’s earnings estimate for AUTL is -$0.23 with a range of -$0.30 to -$0.19. The previous quarter’s EPS was -$0.26. AUTL beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year AUTL has Outperformed its overall industry.
Next quarter’s earnings estimate for AUTL is -$0.23 with a range of -$0.30 to -$0.19. The previous quarter’s EPS was -$0.26. AUTL beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year AUTL has Outperformed its overall industry.

AUTL Sales Forecast

Next quarter’s sales forecast for AUTL is $12.92M with a range of $9.67M to $17.15M. The previous quarter’s sales results were $8.98M. AUTL beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year AUTL has Outperformed its overall industry.
Next quarter’s sales forecast for AUTL is $12.92M with a range of $9.67M to $17.15M. The previous quarter’s sales results were $8.98M. AUTL beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year AUTL has Outperformed its overall industry.

AUTL Stock Forecast FAQ

What is AUTL’s average 12-month price target, according to analysts?
Based on analyst ratings, Autolus Therapeutics Plc’s 12-month average price target is 8.00.
    What is AUTL’s upside potential, based on the analysts’ average price target?
    Autolus Therapeutics Plc has 241.88% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is AUTL a Buy, Sell or Hold?
          Autolus Therapeutics Plc has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Autolus Therapeutics Plc’s price target?
            The average price target for Autolus Therapeutics Plc is 8.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $10.00 ,the lowest forecast is $6.00. The average price target represents 241.88% Increase from the current price of $2.34.
              What do analysts say about Autolus Therapeutics Plc?
              Autolus Therapeutics Plc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of AUTL?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis